Delhi AIIMS issues COVID advisory after staffers test positive

"Gathering especially in canteens must be avoided, a gathering of five or more persons at any place in the office should be avoided. If feeling unwell then should leave the workplace immediately after informing their reporting officers. Such employees should also home quarantine themselves." it added.

All employees who are at higher risk like pregnant employees, older employees or with underlying medical conditions should take extra precautions.

Medical Dialogues team had earlier reported that Serum Institute of India (SII) CEO Adar Poonawalla said it has restarted manufacturing of the COVID-19 vaccine Covishield amid rising numbers of cases of the virus infection. He said the company already has six million booster doses of the Covovax vaccine available and adults must take the booster shot. On Covovax which has been approved as a booster dose for 18 years and above, he said, "We have six million doses ready but the demand is exactly zero."

Covovax booster is now on the CoWin app, he said. Covovax is manufactured through technology transfer from Novavax.  Reacting to reports of COVID-19 vaccines shortage, he said manufacturers are ready but there has been no demand. 

Also Read:Union Health Minister inspects COVID mock drill at RML Hospital